About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Hydroxychloroquine Sulfate
- Company
- National University of Malaysia
- Mechanism
- Mechanism not yet reported
- Route
- Oral
- Recruiting trials
- 50 recruiting
Efficacy results: Not yet reported
50 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 13, 2026
Find a Clinical Trial Near Me
See recruiting studies for Hydroxychloroquine Sulfate and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02714634
Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide
Not yet reported University Hospital, Strasbourg, France 286 participants Est. completion 2029-03 1 siteOther conditions: Rheumatoid Arthritis, Insufficient Response to Methotrexate or LeflunomideView official trial listing → -
Recruiting NCT NCT02735707
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Not yet reported UMC Utrecht 20000 participants Est. completion 2029-02 408 sitesOther conditions: Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia, Community Acquired Pneumonia (CAP), Community Acquired Pneumonia, Severe, COVID-19, Respiratory Tract Infection Acute, Respiratory Tract Infections (RTI), SARS CoV 2 InfectionView official trial listing → -
Recruiting NCT NCT03481881
Pharmacokinetics of Drugs Administered to Children
Duke University 200 participants Est. completion 2033-08-14 1 siteOther conditions: Pediatric ALLView official trial listing → -
Recruiting NCT NCT04354649
Immune-Mediated Pathophysiology And Clinical Triage Program
Not yet reported AHS Cancer Control Alberta 46 participants Est. completion 2030-07 1 site Stand-aloneOther conditions: Arthritis, ArthralgiaView official trial listing → -
Recruiting NCT NCT04381936
Randomised Evaluation of COVID-19 Therapy
Not yet reported University of Oxford 70000 participants Est. completion 2038-09-30 16 sitesOther conditions: PneumoniaView official trial listing → -
Recruiting NCT NCT04678648
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Not yet reported RasCal Therapeutics, Inc. 134 participants Est. completion 2027-01-30 3 sites Stand-aloneOther conditions: Advanced Malignant Solid Neoplasm, RAS Mutation, Lung Cancer, Colon Cancer, Glioblastoma, Pancreatic CancerView official trial listing → -
Recruiting NCT NCT04702256
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Not yet reported Assistance Publique - Hôpitaux de Paris 196 participants Est. completion 2031-12 1 site Stand-aloneOther conditions: Lupus Nephritis, Systemic Lupus Erythematosus (SLE)View official trial listing → -
Recruiting NCT NCT04911816
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
Not yet reported, Not yet reported West Virginia University 40 participants Est. completion 2030-06 1 site Stand-aloneOther conditions: Adenocarcinoma of the PancreasView official trial listing → -
Recruiting NCT NCT04943913
Study of GC101 TIL in Brain Glioma (Soochow2)
Not yet reported Shanghai Juncell Therapeutics 50 participants Est. completion 2027-05-31 1 site Stand-aloneOther conditions: GliomaView official trial listing → -
Recruiting NCT NCT04960072
A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)
Not yet reported Shanghai Juncell Therapeutics 50 participants Est. completion 2029-07-30 1 site Stand-aloneOther conditions: Gastrointestinal TumorView official trial listing → -
Recruiting NCT NCT04967833
A Study of GC101 TIL in Advanced Solid Tumors (TR)
Not yet reported Shanghai Juncell Therapeutics 20 participants Est. completion 2029-04-22 1 site Stand-aloneOther conditions: Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT04976465
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
Not yet reported Qilu Hospital of Shandong University 200 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Systemic Lupus Erythematosus, Pregnancy RelatedView official trial listing → -
Recruiting NCT NCT05036226
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
Not yet reported, Not yet reported Medical University of South Carolina 76 participants Est. completion 2028-05-21 1 site Stand-aloneOther conditions: Prostate Cancer Recurrent, Solid Tumor, AdultView official trial listing → -
Recruiting NCT NCT05041907
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Not yet reported University of Oxford 3800 participants Est. completion 2027-01 7 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Recruiting NCT NCT05087745
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
Not yet reported Shanghai Juncell Therapeutics 50 participants Est. completion 2029-12-10 1 site Stand-aloneOther conditions: Advanced Solid Tumor, Tumor Infiltrating Lymphocytes, Treatment Side Effects, Effects of ImmunotherapyView official trial listing → -
Recruiting NCT NCT05142475
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
Not yet reported Shanghai Juncell Therapeutics 50 participants Est. completion 2027-12-20 1 site Stand-aloneOther conditions: Breast Cancer, Treatment Side Effects, Advanced Breast Cancer, Effects of ImmunotherapyView official trial listing → -
Recruiting NCT NCT05626348
The Clinical Efficacy of Immunomodulators in RA Patients
Not yet reported Qilu Hospital of Shandong University 400 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Arthritis, RheumatoidView official trial listing → -
Recruiting NCT NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Not yet reported Northwestern University 94 participants Est. completion 2030-03-04 1 site Stand-aloneOther conditions: Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Advanced Lung Adenocarcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Urothelial Carcinoma, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Biliary Tract Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic Lung Adenocarcinoma, Metastatic Ovarian Carcinoma, Metastatic Pancreatic Carcinoma, Metastatic Urothelial Carcinoma, Refractory Biliary Tract Carcinoma, Refractory Colorectal Carcinoma, Refractory Gastroesophageal Junction Adenocarcinoma, Refractory Lung Adenocarcinoma, Refractory Ovarian Carcinoma, Refractory Pancreatic Carcinoma, Refractory Urothelial Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT05782335
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
Hospital for Special Surgery, New York 72 participants Est. completion 2026-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT05799378
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Not yet reported NYU Langone Health 330 participants Est. completion 2029-06-30 12 sites Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT05841758
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Not yet reported Hospices Civils de Lyon 140 participants Est. completion 2029-07-01 21 sites Stand-aloneOther conditions: Sarcoidosis, PulmonaryView official trial listing → -
Recruiting NCT NCT05842174
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Not yet reported, Not yet reported VA Office of Research and Development 93 participants Est. completion 2030-10-15 1 site Stand-aloneOther conditions: Hepatocellular CarcinomaView official trial listing → -
Recruiting NCT NCT05953350
A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i
Not yet reported, Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 29 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Inhibition of Autophagy Synergizes Anti-tumor EffectView official trial listing → -
Recruiting NCT NCT05998759
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Not yet reported Beijing Hospital 296 participants Est. completion 2025-12 23 sites Stand-aloneOther conditions: Connective Tissue Diseases, ThrombocytopeniaView official trial listing → -
Recruiting NCT NCT06035887
Novel ERG for Detection of Hydroxychloroquine Retinopathy
King's College Hospital NHS Trust 140 participants Est. completion 2026-05 1 siteOther conditions: Hydroxychloroquine RetinopathyView official trial listing → -
Recruiting NCT NCT06037811
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Not yet reported Tom Appleton 30 participants Est. completion 2028-12 1 siteOther conditions: Inflammatory Arthritis, Immune-related Adverse EventView official trial listing → -
Recruiting NCT NCT06389201
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
Not yet reported Affiliated Hospital of Nantong University 30 participants Est. completion 2034-08-01 1 site Stand-aloneOther conditions: Nasopharyngeal CarcinomaView official trial listing → -
Recruiting NCT NCT06408298
HCQ in Resectable Localized Prostate Cancer
Not yet reported Lionel.D.Lewis, MD 20 participants Est. completion 2029-03 1 site Stand-aloneOther conditions: Resectable Localized Prostate CancerView official trial listing → -
Recruiting NCT NCT06467526
Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss
Not yet reported Chang Gung Memorial Hospital 80 participants Est. completion 2027-03-31 1 site Stand-aloneSubstance use disorderView official trial listing → -
Recruiting NCT NCT06479291
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Not yet reported Yunfeng Cheng 126 participants Est. completion 2026-12 7 sites Stand-aloneOther conditions: Immune Thrombocytopenia With Positive ANA AntibodiesView official trial listing → -
Recruiting NCT NCT06479304
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
Not yet reported Yunfeng Cheng 129 participants Est. completion 2026-12 7 sites Stand-aloneOther conditions: Immune Thrombocytopenia With Positive ANA AntibodiesView official trial listing → -
Recruiting NCT NCT06479317
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Not yet reported Yunfeng Cheng 129 participants Est. completion 2026-12 7 sites Stand-aloneOther conditions: Immune Thrombocytopenia With Positive ANA AntibodiesView official trial listing → -
Recruiting NCT NCT06488950
A Study of TIL in Advanced Solid Tumors (DFGD)
Not yet reported Shanghai Juncell Therapeutics 30 participants Est. completion 2027-06-30 1 site Stand-aloneOther conditions: Advanced Solid Tumor, Tumor Infiltrating Lymphocytes, Treatment Side Effects, Effects of ImmunotherapyView official trial listing → -
Recruiting NCT NCT06652113
Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 796 participants Est. completion 2037-03 2 sites Stand-aloneOther conditions: Recurrent Pregnancy Loss, Euthyroid With Thyroid AntibodiesView official trial listing → -
Recruiting NCT NCT06676384
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
Not yet reported Christian Medical College, Vellore, India 585 participants Est. completion 2029-08 12 sites Stand-aloneOther conditions: IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis, IGA GlomerulonephritisView official trial listing → -
Recruiting NCT NCT06739759
Ovarian Hyperstimulation Syndrome Prevention
Not yet reported Aljazeera Hospital 300 participants Est. completion 2025-07-30 2 sitesOther conditions: Ovarian Hyper Stimulation Syndrome (OHSS)View official trial listing → -
Recruiting NCT NCT06753565
L-carnitine Supplementation in Rheumatoid Arthritis Patients
Not yet reported German University in Cairo 60 participants Est. completion 2025-06 1 site Stand-aloneOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Recruiting NCT NCT06828328
A Study of GC203 TIL in PDCA (RJ)
Not yet reported Shanghai Juncell Therapeutics 10 participants Est. completion 2028-01-31 1 site Stand-aloneOther conditions: Pancreatic Cancer, Pancratic Ductal Adenocarcinoma, Treatment Side Effects, Tumor Infiltrating LymphocytesView official trial listing → -
Recruiting NCT NCT06915701
"Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"
Not yet reported, Not yet reported University of Guadalajara 46 participants Est. completion 2027-01-15 2 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT06971744
Autophagy Maintenance (AUTOMAIN)
Not yet reported Medical University of South Carolina 38 participants Est. completion 2029-06-18 1 site Stand-aloneOther conditions: Ovarian CancerView official trial listing → -
Recruiting NCT NCT07021495
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Leiden University Medical Center 840 participants Est. completion 2029-12-31 8 sitesOther conditions: Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD), CTCL/ Mycosis FungoidesView official trial listing → -
Recruiting NCT NCT07138898
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 site Stand-aloneOther conditions: Rheumatic DiseaseView official trial listing → -
Recruiting NCT NCT07265297
Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis
Not yet reported National Taiwan University Hospital 210 participants Est. completion 2030-12-31 1 siteOther conditions: Steatohepatitis, NonalcoholicView official trial listing → -
Recruiting NCT NCT07280741
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators
Not yet reported University of Sao Paulo General Hospital 200 participants Est. completion 2028-07-30 1 site Stand-aloneOther conditions: Autoimmune Rheumatic DiseasesView official trial listing → -
Recruiting NCT NCT07343635
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea
Not yet reported The Fourth Affiliated Hospital of Zhejiang University School of Medicine 186 participants Est. completion 2027-07-01 1 siteObstructive sleep apneaView official trial listing → -
Recruiting NCT NCT07657793
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
Not yet reported, Not yet reported Chinese SLE Treatment And Research Group 164 participants Est. completion 2029-09-30 1 site Stand-aloneOther conditions: Systemic Lupus Erythematosus, Immune ThrombocytopeniaView official trial listing → -
Recruiting NCT NCT07719140
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
Not yet reported Peking Union Medical College Hospital 198 participants Est. completion 2029-03 8 sites Stand-aloneOther conditions: Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)View official trial listing → -
Recruiting NCT NCT07730723
The Effect of Nicorandil on Rheumatoid Arthritis Patients
Not yet reported, Not yet reported Ain Shams University 70 participants Est. completion 2027-07 1 siteOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Recruiting NCT NCT07825454
Pilot Study of Hydroxychloroquine for the Treatment of AIMSS
Not yet reported Indiana University 35 participants Est. completion 2029-12 1 site Stand-aloneOther conditions: Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain, Breast CancerView official trial listing → -
Recruiting NCT NCT07843381
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
Peking University People's Hospital 60 participants Est. completion 2027-11-20 1 siteOther conditions: Sjögren's Disease, Interstitial Lung DiseaseView official trial listing → -
Completed NCT NCT00089921
SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate
Not yet reported Scios, Inc. 302 participants Est. completion 2005-10Other conditions: Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT00102557
Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus
Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 74 participants Est. completion 2005-10 1 siteOther conditions: Lichen Planus, OralView official trial listing → -
Completed NCT NCT00176982
Plaquenil for Alopecia Areata, Alopecia Totalis
Not yet reported Hordinsky, Maria K., MD 16 participants Est. completion 2008-01 2 sitesOther conditions: Alopecia AreataView official trial listing → -
Completed NCT NCT00259610
Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
Not yet reported University of Alabama at Birmingham 755 participants Est. completion 2009-06 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00311883
Hydroxychloroquine in Cystic Fibrosis
Not yet reported Vanderbilt University 20 participants Est. completion 2007-12 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT00405275
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
Not yet reported US Department of Veterans Affairs 353 participants Est. completion 2012-05 37 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00413361
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS
Not yet reported Assistance Publique - Hôpitaux de Paris 543 participants Est. completion 2011-01 2 sites Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00422227
Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 300 participants Est. completion 2009-03 27 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00430807
Hydroxychloroquine in Giant Cell Arteritis
Not yet reported University Hospital, Toulouse 75 participants Est. completion 2006-12 23 sitesOther conditions: Giant Cell ArteritisView official trial listing → -
Completed NCT NCT00486603
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92 participants Est. completion 2014-01 9 sites Stand-aloneOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Completed NCT NCT00531817
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Not yet reported Hoffmann-La Roche 619 participants Est. completion 2011-03 157 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00568880
Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Not yet reported Abramson Cancer Center at Penn Medicine 25 participants Est. completion 2011-06-22 1 site Stand-aloneOther conditions: Multiple Myeloma and Plasma Cell NeoplasmView official trial listing → -
Completed NCT NCT00632866
Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Not yet reported Assistance Publique - Hôpitaux de Paris 120 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Primary Sjögren's SyndromeView official trial listing → -
Terminated NCT NCT00706797
Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 141 participants Est. completion 2010-05 45 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00714181
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors
Not yet reported Abramson Cancer Center at Penn Medicine 38 participants Est. completion 2013-06 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00720798
An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies
Not yet reported Hoffmann-La Roche 2067 participants Est. completion 2013-04 295 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00726596
Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Not yet reported Rutgers, The State University of New Jersey 64 participants Est. completion 2018-01 5 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00728845
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer
Not yet reported, Not yet reported University of Medicine and Dentistry of New Jersey 8 participants Est. completion 2010-12-21 2 sites Stand-aloneOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00764725
Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)
Not yet reported Karolinska Institutet 487 participants Est. completion 2008-12Other conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00765765
Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer
Not yet reported, Not yet reported University of Medicine and Dentistry of New Jersey 6 participants Est. completion 2011-12 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00771056
Hydroxychloroquine in Untreated B-CLL Patients
Not yet reported Northwell Health 23 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: B-Cell Chronic Lymphocytic LeukemiaView official trial listing → -
Status unknown NCT NCT00809237
Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Not yet reported, Not yet reported National University Hospital, Singapore 71 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT00813423
Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2023-07-18 2 sites Stand-aloneOther conditions: Adult Solid NeoplasmView official trial listing → -
Completed NCT NCT00848354
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
Not yet reported Pfizer 429 participants Est. completion 2013-04 33 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT00908089
TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis
Not yet reported University of Helsinki 100 participants Est. completion 2015-12 13 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00909831
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment
Not yet reported Abramson Cancer Center at Penn Medicine 40 participants Est. completion 2013-11 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00946790
To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets
Not yet reported Sandoz 72 participants Est. completion 1993-12 Stand-aloneOther conditions: Immunosuppression, RheumatismView official trial listing → -
Completed NCT NCT00962845
Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Not yet reported Rutgers, The State University of New Jersey 20 participants Est. completion 2013-05-30 1 site Stand-aloneOther conditions: Melanoma (Skin)View official trial listing → -
Completed NCT NCT01006369
Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Not yet reported Rutgers, The State University of New Jersey 38 participants Est. completion 2016-04-27 4 sites Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT01015547
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Not yet reported Helsinki University Central Hospital 60 participants Est. completion 2013-12 6 sites Stand-aloneOther conditions: Juvenile Idiopathic ArthritisView official trial listing → -
Completed NCT NCT01023737
Hydroxychloroquine + Vorinostat in Advanced Solid Tumors
Not yet reported The University of Texas Health Science Center at San Antonio 72 participants Est. completion 2023-01-08 1 site Stand-aloneOther conditions: Malignant Solid TumourView official trial listing → -
Terminated NCT NCT01026844
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
Not yet reported Massachusetts General Hospital 27 participants Est. completion 2012-11 1 site Stand-aloneOther conditions: Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT01040195
Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
Not yet reported Sanjay Gandhi Postgraduate Institute of Medical Sciences 33 participants Est. completion 2012-12 1 siteOther conditions: Seronegative SpondyloarthropathiesView official trial listing → -
Status unknown NCT NCT01067417
Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Not yet reported Medical Research Council 83 participants Est. completion 2011-02Other conditions: HIV InfectionsView official trial listing → -
Withdrawn NCT NCT01073852
Hydroxychloroquine Efficacy in Chronic Urticaria
Not yet reported Vanderbilt University Est. completion 2012-06Other conditions: Chronic UrticariaView official trial listing → -
Status unknown NCT NCT01078779
The Chloroquine for Influenza Prevention Trial
Not yet reported National University Hospital, Singapore 1516 participants Est. completion 2010-08 1 siteOther conditions: InfluenzaView official trial listing → -
Completed NCT NCT01128296
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Not yet reported, Not yet reported Amer Zureikat 35 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01132118
Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
Not yet reported Brigham and Women's Hospital 30 participants Est. completion 2012-06 1 siteOther conditions: Rheumatoid Arthritis, Insulin ResistanceView official trial listing → -
Terminated NCT NCT01144169
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Not yet reported University of Pittsburgh 7 participants Est. completion 2016-09 2 sites Stand-aloneOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01148043
Pharmacological Treatment In Osteoarthritis
Not yet reported Maasstad Hospital 200 participants Est. completion 2014-09 6 sites Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT01206530
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 50 participants Est. completion 2017-09 1 siteOther conditions: Rectal Cancer, Colon Cancer, Metastasis, AdenocarcinomaView official trial listing → -
Completed NCT NCT01207739
Persistent Lyme Empiric Antibiotic Study Europe
Not yet reported Radboud University Medical Center 280 participants Est. completion 2014-10 2 sitesOther conditions: Lyme Disease, Borrelia InfectionView official trial listing → -
Completed NCT NCT01211834
Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Not yet reported JW Pharmaceutical 90 participants Est. completion 2010-10 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT01227135
Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia
Not yet reported Lynn McMahon 66 participants 3 sitesOther conditions: LeukemiaView official trial listing → -
Status unknown NCT NCT01232660
Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)
Not yet reported St Stephens Aids Trust 12 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: HIV InfectionView official trial listing → -
Completed NCT NCT01256736
To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis
Not yet reported JW Pharmaceutical 89 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01266057
Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer
Not yet reported M.D. Anderson Cancer Center 143 participants Est. completion 2021-02-11 1 site Stand-aloneOther conditions: Advanced CancersView official trial listing → -
Status unknown NCT NCT01272310
Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Not yet reported, Not yet reported Sheba Medical Center 36 participants Est. completion 2013-07 Stand-aloneOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT01273805
Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer
Not yet reported Dana-Farber Cancer Institute 20 participants Est. completion 2014-02 2 sites Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01284725
Weaning of Immunosuppression in Nephritis of Lupus
Not yet reported Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2018-12-31 1 siteOther conditions: Nephritis of LupusView official trial listing → -
Completed NCT NCT01313208
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
Not yet reported Amgen 210 participants Est. completion 2013-05 47 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01326533
Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes
Not yet reported University of Pittsburgh 32 participants Est. completion 2014-12 1 site Stand-alonePrediabetesView official trial listing → -
Completed NCT NCT01379573
Preventive Approach to Congenital Heart Block With Hydroxychloroquine
Not yet reported NYU Langone Health 74 participants Est. completion 2020-07-16 1 site Stand-aloneOther conditions: Congenital Heart Block, Neonatal Lupus, Autoantibody-Associated Heart BlockView official trial listing → -
Completed NCT NCT01396200
Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
Not yet reported Abramson Cancer Center at Penn Medicine 6 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: MyelomaView official trial listing → -
Terminated NCT NCT01417403
Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases
Not yet reported Virginia Commonwealth University 10 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: Bone Metastases, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT01475149
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Hospital for Special Surgery, New York 33 participants Est. completion 2016-08 1 siteOther conditions: Antiphospholipid Syndrome, Thrombophilia Due to Antiphospholipid Antibody, Systemic Lupus ErythematosusView official trial listing → -
Active, not recruiting NCT NCT01480154
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2027-03-31 1 site Stand-aloneOther conditions: Advanced Malignant Solid Neoplasm, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage III Renal Cell Cancer AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Stage IV Prostate Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7View official trial listing → -
Status unknown NCT NCT01491815
Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
Not yet reported Karolinska Institutet 812 participants Est. completion 2023-12 30 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01495403
Treatment of Muscle Cramps in Patients With Liver Cirrhosis
Not yet reported Mayo Clinic 3 participants Est. completion 2015-04 1 site Stand-aloneOther conditions: Liver Cirrhosis, Muscle CrampsView official trial listing → -
Completed NCT NCT01506973
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 119 participants Est. completion 2022-03 1 site Stand-aloneOther conditions: Advanced Adenocarcinoma, Metastatic AdenocarcinomaView official trial listing → -
Completed NCT NCT01509989
International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 307 participants Est. completion 2016-03 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01510119
Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 40 participants Est. completion 2017-01-05 3 sites Stand-aloneOther conditions: Metastatic Clear Cell Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT01537315
Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
Not yet reported University of Arkansas 8 participants Est. completion 2013-09 3 sites Stand-aloneCardiovascular disease Other conditions: Kidney Failure, Chronic, ArteriosclerosisView official trial listing → -
Status unknown NCT NCT01541449
Plaqenil Role in Prevention of Age Related Macular Degeneration
Ziv Hospital 30 participants Est. completion 2012-04 1 siteOther conditions: Age Related Macular DegenerationView official trial listing → -
Completed NCT NCT01549184
Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
Henri Mondor University Hospital 40 participants Est. completion 2011-12Other conditions: Immune Thrombocytopenia, Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01550367
Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)
Not yet reported, Not yet reported Leonard Appleman 30 participants Est. completion 2019-02 7 sites Stand-aloneOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01551069
Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion
Not yet reported Sanofi 103 participants Est. completion 2014-04 22 sitesOther conditions: Cutaneous Lupus Erythematosus-Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01573754
Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Not yet reported The University of Texas Medical Branch, Galveston 48 participants Est. completion 2021-07-06 1 site Stand-aloneOther conditions: Porphyria Cutanea TardaView official trial listing → -
Completed NCT NCT01601028
Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
Not yet reported Seoul National University Hospital 39 participants Est. completion 2013-08 1 siteOther conditions: Autoimmune Diseases, Sjogren's Syndrome, Dry EyeView official trial listing → -
Completed NCT NCT01645176
Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
Not yet reported Stanford University 21 participants Est. completion 2016-10 1 site Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT01649947
Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Not yet reported Rutgers, The State University of New Jersey 32 participants Est. completion 2015-06-30 2 sites Stand-aloneOther conditions: Non-small Cell Lung Cancer, Advanced Non-small Cell Lung Cancer, Recurrent Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT01687179
Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Not yet reported Brigham and Women's Hospital 14 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: LymphangioleiomyomatosisView official trial listing → -
Completed NCT NCT01689987
Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Not yet reported OHSU Knight Cancer Institute 18 participants 1 site Stand-aloneOther conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell MyelomaView official trial listing → -
Completed NCT NCT01760421
The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis
Not yet reported National Taiwan University Hospital 40 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Hashimoto ThyroiditisView official trial listing → -
Completed NCT NCT01783106
Antibiotics and Hydroxychloroquine in Crohn's
Not yet reported Royal Liverpool University Hospital 59 participants Est. completion 2019-09-30 1 site Stand-aloneOther conditions: Crohn's DiseaseView official trial listing → -
Terminated NCT NCT01784523
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Not yet reported Hospital for Special Surgery, New York 11 participants Est. completion 2015-09-30 1 site Stand-aloneOther conditions: Antiphospholipid SyndromeView official trial listing → -
Terminated NCT NCT01833845
Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C
Not yet reported, Not yet reported BioLineRx, Ltd. 4 participants Est. completion 2014-04 2 sites Stand-aloneOther conditions: Hepatitis CView official trial listing → -
Terminated NCT NCT01842594
A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
Not yet reported Shin Kong Wu Ho-Su Memorial Hospital 13 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: SarcomaView official trial listing → -
Completed NCT NCT01870128
Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial
Not yet reported All India Institute of Medical Sciences 60 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01897116
A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
Not yet reported Abramson Cancer Center at Penn Medicine 8 participants Est. completion 2016-10-05 1 siteOther conditions: MelanomaView official trial listing → -
Terminated NCT NCT01946880
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 102 participants Est. completion 2019-07-03 19 sites Stand-aloneOther conditions: Systemic Lupus Erythematosus, SLEView official trial listing → -
Completed NCT NCT01978184
Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine
Not yet reported Nathan Bahary, MD 104 participants Est. completion 2018-02-28 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT02026232
Metabolic Effects of Hydroxychloroquine
Not yet reported Washington University School of Medicine 21 participants Est. completion 2022-12-15 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02057250
To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis
Not yet reported Sanofi 217 participants Est. completion 2016-03 53 sites Stand-aloneOther conditions: RAView official trial listing → -
Completed NCT NCT02124681
Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer
Not yet reported University of Pittsburgh 34 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT02200146
Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).
Not yet reported University of Milano Bicocca 94 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: Pulmonary SarcoidosisView official trial listing → -
Completed NCT NCT02219347
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 74 participants Est. completion 2017-08 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02232243
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
Not yet reported Peng Wang, MD PhD 10 participants Est. completion 2018-12-01 1 site Stand-aloneOther conditions: Solid TumorView official trial listing → -
Completed NCT NCT02257424
Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 50 participants Est. completion 2021-10 4 sitesOther conditions: Advanced BRAF Mutant MelanomaView official trial listing → -
Terminated NCT NCT02303405
Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
Not yet reported Charles Drew University of Medicine and Science 22 participants Est. completion 2017-11 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02316340
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
Not yet reported The University of Texas Health Science Center at San Antonio 42 participants Est. completion 2018-04-16 1 site Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT02349061
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Not yet reported Janssen Research & Development, LLC 102 participants Est. completion 2019-03-13 43 sites Stand-aloneOther conditions: Lupus Erythematosus, SystemicView official trial listing → -
Completed NCT NCT02351752
Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study
Not yet reported LLiu 20 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: Primary IgA NephropathyView official trial listing → -
Completed NCT NCT02374021
Treatments Against RA and Effect on FDG-PET/CT
Not yet reported Brigham and Women's Hospital 159 participants Est. completion 2021-05 31 sitesOther conditions: Arthritis, RheumatoidView official trial listing → -
Terminated NCT NCT02414776
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
Not yet reported Western Regional Medical Center 3 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Terminated NCT NCT02421575
Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance
Not yet reported Rutgers, The State University of New Jersey 4 participants Est. completion 2016-02-26 1 site Stand-aloneOther conditions: Prostate CarcinomaView official trial listing → -
Completed NCT NCT02433184
Very Early Versus Delayed Etanercept in Patients With RA
Not yet reported University of Leeds 120 participants Est. completion 2019-07 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT02444728
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Not yet reported Chinese SLE Treatment And Research Group 50 participants Est. completion 2018-12-30 15 sitesOther conditions: ThrombocytopeniaView official trial listing → -
Completed NCT NCT02451748
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
Not yet reported University of Illinois Chicago 32 participants Est. completion 2017-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT02466581
Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
Not yet reported Karolinska Institutet 25 participants Est. completion 2023-12 8 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02470468
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer
Not yet reported, Not yet reported SOTIO a.s. 105 participants Est. completion 2021-11 18 sites Stand-aloneOther conditions: Stage IV Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT02475915
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Not yet reported, Not yet reported SEARCH Research Foundation 15 participants Est. completion 2016-03 1 site Stand-aloneOther conditions: Acute HIV InfectionView official trial listing → -
Completed NCT NCT02476084
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
University of Oxford 43 participants Est. completion 2021-10-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT02550964
Incidence and Risk Factor of Hydroxychloroquine and Chloroquine Retinopathy
Asan Medical Center 124 participants Est. completion 2019-01 1 siteOther conditions: Toxic MaculopathyView official trial listing → -
Status unknown NCT NCT02551575
Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis
Not yet reported, Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 468 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT02595346
Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
Not yet reported University Hospital, Rouen 25 participants Est. completion 2020-08-05 1 site Stand-aloneOther conditions: Antiphospholipid Syndrome (APS)View official trial listing → -
Terminated NCT NCT02603146
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 144 participants Est. completion 2022-11-01 14 sites Stand-aloneOther conditions: Healthy Participants, Rheumatoid Arthritis (RA) PreventionView official trial listing → -
Terminated NCT NCT02615938
Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)
Not yet reported Matthias Griese 35 participants Est. completion 2020-09-09 9 sites Stand-aloneOther conditions: Interstitial Lung Disease, Diffuse Parenchymal Lung Disease, Children´s Interstitial Lung DiseaseView official trial listing → -
Terminated NCT NCT02631252
Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia
Not yet reported Alison Sehgal, MD, MS 1 participants Est. completion 2017-10-02 1 site Stand-aloneOther conditions: Leukemia, Acute MyelogenousView official trial listing → -
Completed NCT NCT02644499
Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis
Not yet reported Jawaharlal Institute of Postgraduate Medical Education & Research 186 participants Est. completion 2017-09-15 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02648464
Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
Not yet reported Helsinki University Central Hospital 125 participants Est. completion 2019-12-31 6 sites Stand-aloneCardiovascular disease Other conditions: Acute Coronary Syndrome, Inflammation, Hydroxychloroquine, Antirheumatic AgentsView official trial listing → -
Status unknown NCT NCT02779114
RETRO (REduction of Therapy in RA Patients in Ongoing Remission)
Not yet reported University of Erlangen-Nürnberg Medical School 318 participants Est. completion 2018-06 12 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02842814
Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus
Not yet reported Peking Union Medical College Hospital 333 participants Est. completion 2022-09-28 5 sites Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT02873936
Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment
Not yet reported Gilead Sciences 449 participants Est. completion 2018-06-26 104 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02874287
Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 35 participants Est. completion 2019-06-01 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02910076
The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion
Not yet reported, Not yet reported Hadassah Medical Organization 40 participants Stand-aloneOther conditions: Diabetes Type TwoView official trial listing → -
Completed NCT NCT02913157
Hydroxychloroquine in Primary Progressive Multiple Sclerosis
Not yet reported University of Calgary 35 participants Est. completion 2021-06 1 site Stand-aloneOther conditions: Multiple Sclerosis, Primary ProgressiveView official trial listing → -
Completed NCT NCT02942381
A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy
Not yet reported Peking University First Hospital 60 participants Est. completion 2018-01-08 1 siteOther conditions: IgA Patients, HydroxychloroquineView official trial listing → -
Status unknown NCT NCT03008148
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Not yet reported, Not yet reported Johnpro Biotech, Inc. 288 participants Est. completion 2025-04 2 sitesOther conditions: GlioblastomaView official trial listing → -
Completed NCT NCT03015324
Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
Not yet reported Peng Wang, MD PhD 38 participants Est. completion 2021-02-02 1 site Stand-aloneOther conditions: Solid TumorView official trial listing → -
Completed NCT NCT03019926
Lupus and Observance
University Hospital Center of Martinique 200 participants Est. completion 2018-07-19 1 siteOther conditions: Systemic Lupus, Skin LupusView official trial listing → -
Terminated NCT NCT03025087
Hydroxychloroquine and Cognitive Function After Surgery
Not yet reported Duke University 24 participants Est. completion 2024-04-19 1 site Stand-aloneOther conditions: Individuals Undergoing Cardiac and General SurgeryView official trial listing → -
Active, not recruiting NCT NCT03032406
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 53 participants Est. completion 2027-01-01 1 site Stand-aloneOther conditions: Breast Cancer Stage IIBView official trial listing → -
Completed NCT NCT03037437
Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
Not yet reported The University of Texas Health Science Center at San Antonio 37 participants Est. completion 2025-06-27 1 site Stand-aloneOther conditions: Hepatocellular CancerView official trial listing → -
Completed NCT NCT03081702
A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer
Not yet reported, Not yet reported University Health Network, Toronto 13 participants Est. completion 2019-08-27 1 site Stand-aloneOther conditions: Platinum-resistant Epithelial Ovarian CancerView official trial listing → -
Completed NCT NCT03122431
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases
Not yet reported University of Sao Paulo General Hospital 93 participants Est. completion 2021-03-30 1 siteOther conditions: Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous LupusView official trial listing → -
Status unknown NCT NCT03165136
Hydroxychloroquine for Prevention of Recurrent Miscarriage.
Not yet reported University Hospital, Brest 300 participants Est. completion 2026-02-01 18 sites Stand-aloneOther conditions: Recurrent Miscarriage, First Trimester AbortionView official trial listing → -
Status unknown NCT NCT03180190
Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)
Assiut University 50 participants Est. completion 2018-07-28Other conditions: Autoimmune DiseasesView official trial listing → -
Completed NCT NCT03215264
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 20 participants Est. completion 2020-06-01 1 site Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT03229746
Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia
Not yet reported Assiut University 40 participants Est. completion 2018-06-01 1 site Stand-aloneOther conditions: Immune ThrombocytopeniaView official trial listing → -
Completed NCT NCT03275870
Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
Not yet reported, Not yet reported Elena Gonzalez Brant, MD 17 participants Est. completion 2019-06-30 1 site Stand-aloneOther conditions: Hidradenitis Suppurativa, Hidradenitis, Acne Inversa, Boils, Follicular Occlusion Triad, Follicular Occlusion TetradView official trial listing → -
Completed NCT NCT03283566
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT
Not yet reported The Cleveland Clinic 9 participants Est. completion 2020-05-31 1 siteOther conditions: Chronic Pancreatitis, Insulin Dependent DiabetesView official trial listing → -
Status unknown NCT NCT03305263
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
Not yet reported Copenhagen University Hospital, Rigshospitalet 186 participants Est. completion 2023-01 1 site Stand-aloneOther conditions: Recurrent Pregnancy LossView official trial listing → -
Completed NCT NCT03316092
Monitoring and Preventing Hydroxychloroquine, Plaquenil, Toxicity.
Dr. S.S. Michel Clinic 1000 participants Est. completion 2017-10-10 1 siteOther conditions: Hydroxychloroquine ToxicityView official trial listing → -
Terminated NCT NCT03344172
Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer
Not yet reported Nathan Bahary, MD 32 participants Est. completion 2019-04-30 1 site Stand-aloneOther conditions: Pancreatic Cancer ResectableView official trial listing → -
Withdrawn NCT NCT03400254
Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine Est. completion 2019-11-12 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03400865
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
Not yet reported Zhebao Wu 30 participants Est. completion 2020-12-30 9 sites Stand-aloneOther conditions: Resistance, Disease, ProlactinomaView official trial listing → -
Terminated NCT NCT03428945
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 273 participants Est. completion 2022-10-31 51 sites Stand-aloneOther conditions: Type1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03449758
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
Not yet reported Sanofi 84 participants Est. completion 2019-07-31 33 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT03513211
Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer
Not yet reported, Not yet reported St Vincent's Hospital, Sydney 12 participants Est. completion 2023-10-30 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT03540810
Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome
Not yet reported University Hospital, Angers 300 participants Est. completion 2022-10-15 1 siteOther conditions: Primary Antiphospholipid SyndromeView official trial listing → -
Active, not recruiting NCT NCT03598595
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-05-31 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT03636152
Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
Not yet reported VA Office of Research and Development 100 participants Est. completion 2024-01-31 1 siteChronic kidney diseaseCardiovascular disease Other conditions: Inflammation, Atherosclerosis, Aortic StiffnessView official trial listing → -
Completed NCT NCT03660059
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
Not yet reported Astellas Pharma China, Inc. 385 participants Est. completion 2021-11-02 43 sites Stand-aloneOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Status unknown NCT NCT03671174
Immunosuppressant Regimens for Living Fetuses Study
Not yet reported RenJi Hospital 420 participants Est. completion 2023-02 1 site Stand-aloneOther conditions: Undifferentiated Connective Tissue Disease, Recurrent Pregnancy LossView official trial listing → -
Status unknown NCT NCT03687905
Proliferative Lupus Nephritis Treatment With Chloroquine and Hydroxychloroquine
Tanta University 60 participants Est. completion 2019-09-30 1 siteOther conditions: Proliferative Nephritis, Chloroquine RetinopathyView official trial listing → -
Status unknown NCT NCT03754179
Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma
Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 63 participants Est. completion 2022-07-01 1 site Stand-aloneOther conditions: MelanomaView official trial listing → -
Completed NCT NCT03774472
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2024-04-17 1 site Stand-aloneOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT03802188
Hydroxychloroquine in Systemic Lupus Erythematosus
McGill University Health Centre/Research Institute of the McGill University Health Centre 3700 participants Est. completion 2025-03-31 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT03813771
Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification
Not yet reported University of Leeds 106 participants Est. completion 2023-02 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT03825289
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
Not yet reported University of Utah 25 participants Est. completion 2025-08-03 2 sites Stand-aloneOther conditions: Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer, Unresectable Pancreatic CarcinomaView official trial listing → -
Completed NCT NCT03856866
Hydroxychloroquine Administration for Reduction of Pexophagy
Not yet reported The Hospital for Sick Children 3 participants Est. completion 2020-05-05 1 site Stand-aloneOther conditions: Zellweger Syndrome, Peroxisome Biogenesis DisordersView official trial listing → -
Status unknown NCT NCT03863405
Metformin Use in Rheumatoid Arthritis
Not yet reported Ain Shams University 60 participants Est. completion 2020-01-09 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Withdrawn NCT NCT03929211
CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome
Not yet reported, Not yet reported Wake Forest University Health Sciences Est. completion 2027-07 2 sites Stand-aloneOther conditions: Myelodysplastic Syndromes, Progressive DiseaseView official trial listing → -
Completed NCT NCT03979651
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma
Not yet reported Hospices Civils de Lyon 29 participants Est. completion 2023-01-03 5 sites Stand-aloneOther conditions: Metastatic NRAS MelanomaView official trial listing → -
Status unknown NCT NCT04005768
Effect of Hydroxychloroquine Sulphate in Healthy Lean Females
Not yet reported Universitaire Ziekenhuizen KU Leuven 10 participants Est. completion 2019-10-01 Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT04005781
Effect of Bitter in Overweight Female Volunteers
Not yet reported Universitaire Ziekenhuizen KU Leuven 40 participants Est. completion 2020-10-01 Stand-aloneOther conditions: ObesityView official trial listing → -
Withdrawn NCT NCT04007562
Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency
Assistance Publique - Hôpitaux de Paris Est. completion 2019-11-04 1 siteOther conditions: LIPIN1 DeficiencyView official trial listing → -
Completed NCT NCT04010110
Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics
The Eye Center and The Eye Foundation for Research in Ophthalmology 63 participants Est. completion 2019-06-01 1 siteOther conditions: Hydroxychloroquine Toxic RetinopathyView official trial listing → -
Completed NCT NCT04011410
Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer
Not yet reported Patrick Hensley 20 participants Est. completion 2024-03-08 1 site Stand-aloneOther conditions: Prostate Cancer RecurrentView official trial listing → -
Status unknown NCT NCT04022421
Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis
Not yet reported Assiut University 50 participants Est. completion 2019-10 1 site Stand-aloneOther conditions: Behcet's Syndrome, Vascular TypeView official trial listing → -
Status unknown NCT NCT04066803
Optimal MTX Dose With Folic Acid Randomized Case-control Trial
Not yet reported Sun Yat-sen University 160 participants Est. completion 2020-07-30 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT04077957
Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
Not yet reported Nanfang Hospital, Southern Medical University 100 participants Est. completion 2022-07-02 1 site Stand-aloneOther conditions: Ankylosing Spondylitis, SpondyloarthritisView official trial listing → -
Terminated NCT NCT04120883
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)
Not yet reported, Not yet reported University of Michigan 8 participants Est. completion 2024-08-05 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT04132505
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
Not yet reported M.D. Anderson Cancer Center 34 participants Est. completion 2026-03-24 1 site Stand-aloneOther conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8View official trial listing → -
Completed NCT NCT04145297
Ulixertinib (BVD-523) and Hydroxychloroquine in Patients W Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas
Not yet reported University of Utah 16 participants Est. completion 2022-08-18 1 site Stand-aloneOther conditions: Gastrointestinal NeoplasmsView official trial listing → -
Completed NCT NCT04153201
Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
Not yet reported National and Kapodistrian University of Athens 50 participants Est. completion 2019-10-16 1 site Stand-aloneOther conditions: Antiphospholipid SyndromeView official trial listing → -
Status unknown NCT NCT04161339
Anti-Inflammatory Drug and Endothelial Function
Not yet reported Instituto de Cardiologia do Rio Grande do Sul 50 participants Est. completion 2020-06-30 1 site Stand-aloneCardiovascular disease Other conditions: Endothelial Dysfunction, Sleep Apnea, AtherosclerosisView official trial listing → -
Active, not recruiting NCT NCT04201457
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Not yet reported, Not yet reported Pediatric Brain Tumor Consortium 57 participants Est. completion 2026-12-31 15 sites Stand-aloneOther conditions: Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade Glioma of Brain With Neurofibromatosis Type 1View official trial listing → -
Terminated NCT NCT04214418
Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced Malignancies
Not yet reported, Not yet reported Columbia University 27 participants Est. completion 2022-07-01 2 sites Stand-aloneOther conditions: Gastrointestinal CancerView official trial listing → -
Completed NCT NCT04261517
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
Not yet reported Shanghai Public Health Clinical Center 30 participants Est. completion 2020-02-25 2 sites Stand-aloneOther conditions: Pneumonia, Pneumocystis, Coronavirus, COVID-19View official trial listing → -
Withdrawn NCT NCT04275778
HYDROxychloroquine in Syndrome Primary AntiPhospholipid
Not yet reported Assistance Publique - Hôpitaux de Paris Est. completion 2025-10-02 1 siteOther conditions: Antiphospholipid Syndrome in Pregnancy, AnticoagulantsView official trial listing → -
Completed NCT NCT04303507
Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting
Not yet reported University of Oxford 4652 participants Est. completion 2022-03-22 25 sites Stand-aloneOther conditions: COVID19, Coronavirus, Acute Respiratory IllnessesView official trial listing → -
Completed NCT NCT04304053
Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention
Not yet reported Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 2300 participants Est. completion 2020-06-15 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04307693
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
Not yet reported Asan Medical Center 65 participants Est. completion 2020-04-30 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04308668
Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
Not yet reported University of Minnesota 1312 participants Est. completion 2020-05-20 5 sites Stand-aloneOther conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection, Coronavirus, Coronavirus InfectionsView official trial listing → -
Terminated NCT NCT04310462
Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine
Not yet reported University of California, San Francisco 65 participants Est. completion 2024-02-28 1 site Stand-aloneOther conditions: Rheumatic DiseasesView official trial listing → -
Completed NCT NCT04315948
Trial of Treatments for COVID-19 in Hospitalized Adults
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 1552 participants Est. completion 2023-09-25 62 sites Stand-aloneOther conditions: Corona Virus InfectionView official trial listing → -
Terminated NCT NCT04316494
Hydroxychloroquine in ANCA Vasculitis Evaluation
Not yet reported Guy's and St Thomas' NHS Foundation Trust 43 participants Est. completion 2025-05-15 18 sites Stand-aloneOther conditions: ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Wegener GranulomatosisView official trial listing → -
Completed NCT NCT04318015
Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)
Not yet reported National Institute of Respiratory Diseases, Mexico 289 participants Est. completion 2021-03-31 1 site Stand-aloneOther conditions: COVID-19, Severe Acute Respiratory SyndromeView official trial listing → -
Terminated NCT NCT04318444
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
Not yet reported, Not yet reported Columbia University 10 participants Est. completion 2021-03-31 1 site Stand-aloneOther conditions: COVID-19, Corona Virus InfectionView official trial listing → -
Status unknown NCT NCT04320277
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
Not yet reported, Not yet reported Hospital of Prato 200 participants Est. completion 2020-07-30 1 siteOther conditions: Pharmacological ActionView official trial listing → -
Status unknown NCT NCT04321616
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
Not yet reported, Not yet reported Oslo University Hospital 700 participants Est. completion 2020-11 1 siteOther conditions: SARS-CoV Infection, COVID 19, Acute Respiratory Distress Syndrome ARDSView official trial listing → -
Completed NCT NCT04322123
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
Not yet reported Hospital do Coracao 667 participants Est. completion 2020-06-02 28 sites Stand-aloneOther conditions: Coronavirus InfectionsView official trial listing → -
Terminated NCT NCT04322396
Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19
Not yet reported Chronic Obstructive Pulmonary Disease Trial Network, Denmark 117 participants Est. completion 2021-02-02 8 sitesOther conditions: Virus Diseases, Infection Viral, Corona Virus InfectionView official trial listing → -
Status unknown NCT NCT04323345
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus
Not yet reported Misr University for Science and Technology 1000 participants Est. completion 2021-01-15 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04323631
Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
Not yet reported Rambam Health Care Campus Est. completion 2020-04-30 Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04325893
Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease
Not yet reported University Hospital, Angers 259 participants Est. completion 2020-06-18 47 sitesOther conditions: CoronavirusView official trial listing → -
Status unknown NCT NCT04326725
Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
Istinye University 80 participants Est. completion 2020-09-01 1 siteOther conditions: Pneumonitis, Coronavirus InfectionView official trial listing → -
Status unknown NCT NCT04328272
Effectiveness of Hydroxychloroquine in Covid-19 Patients
Not yet reported Prof. Dr. Umar Farooq 75 participants Est. completion 2020-06-28 1 site Stand-aloneOther conditions: COVID19View official trial listing → -
Suspended NCT NCT04329572
Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19
Not yet reported Azidus Brasil 400 participants Est. completion 2023-06-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04329611
ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease
Not yet reported Dr. Michael Hill 148 participants Est. completion 2020-07-20 2 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04329832
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19
Not yet reported Intermountain Health Care, Inc. 85 participants Est. completion 2021-01-01 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04329923
The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)
Not yet reported Ravi Amaravadi, MD 173 participants Est. completion 2020-11-13 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04330495
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection
Not yet reported Instituto de Investigación Marqués de Valdecilla Est. completion 2021-08-27 Stand-aloneOther conditions: COVID 19, Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak InhibitorsView official trial listing → -
Status unknown NCT NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19
Not yet reported, Not yet reported Fasa University of Medical Sciences 30 participants Est. completion 2020-05-20 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04331834
Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic
Not yet reported Barcelona Institute for Global Health 275 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04332094
Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 276 participants Est. completion 2021-07 7 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04332991
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
Not yet reported Massachusetts General Hospital 479 participants Est. completion 2020-07-23 40 sitesOther conditions: Coronavirus, Acute Respiratory Infection, SARS-CoV InfectionView official trial listing → -
Completed NCT NCT04333225
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers
Not yet reported Baylor Research Institute 221 participants Est. completion 2020-06-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04333589
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
Not yet reported Peking University First Hospital 210 participants Est. completion 2020-09-15 8 sitesOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04333654
Hydroxychloroquine in Outpatient Adults With COVID-19
Not yet reported Sanofi 8 participants Est. completion 2020-05-26 7 sites Stand-aloneOther conditions: Coronavirus InfectionView official trial listing → -
Completed NCT NCT04334148
Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine
Not yet reported Adrian Hernandez 1360 participants Est. completion 2021-01-09 34 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04334382
Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19
Not yet reported Intermountain Health Care, Inc. 1550 participants Est. completion 2021-12-31 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04334928
Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel
Not yet reported Plan Nacional sobre el Sida (PNS) 1002 participants Est. completion 2021-07-11 65 sites Stand-aloneOther conditions: Coronavirus InfectionView official trial listing → -
Suspended NCT NCT04334967
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
Not yet reported Providence Health & Services 13 participants Est. completion 2022-05-27 1 site Stand-aloneOther conditions: COVID-19, Corona Virus Infection, SARS-CoV-2, 2019-nCoV, 2019 Novel CoronavirusView official trial listing → -
Completed NCT NCT04335084
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
Not yet reported ProgenaBiome 254 participants Est. completion 2024-04-11 1 site Stand-aloneOther conditions: COVID-19, Coronavirus Infection, Sars-CoV2, Corona Virus Infection, COVID, Coronavirus, Coronavirus-19, Coronavirus 19View official trial listing → -
Terminated NCT NCT04335305
Checkpoint Blockade in COVID-19 Pandemic
Not yet reported MedSIR 12 participants Est. completion 2021-06-21 7 sitesOther conditions: COVID-19, Pneumonia, ViralView official trial listing → -
Terminated NCT NCT04335552
Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection
Not yet reported Duke University 11 participants Est. completion 2020-06-26 4 sites Stand-aloneOther conditions: SARS-CoV-2View official trial listing → -
Terminated NCT NCT04336332
Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19
Not yet reported Rutgers, The State University of New Jersey 75 participants Est. completion 2020-10-14 5 sites Stand-aloneOther conditions: SARS-CoV-2, COVID-19View official trial listing → -
Completed NCT NCT04338698
Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT
Not yet reported Shehnoor Azhar 550 participants Est. completion 2020-11-22 11 sites Stand-aloneOther conditions: COVID 19View official trial listing → -
Status unknown NCT NCT04340349
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals
Not yet reported Instituto Nacional de Rehabilitacion 214 participants Est. completion 2021-06-30 1 site Stand-aloneOther conditions: Hydroxychloroquine, Antimalarials, Enzyme Inhibitors, Antirheumatic AgentsView official trial listing → -
Terminated NCT NCT04340544
Hydroxychloroquine for the Treatment of Mild COVID-19 Disease
Not yet reported University Hospital Tuebingen 17 participants Est. completion 2020-10-12 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04341441
Will Hydroxychloroquine Impede or Prevent COVID-19
Not yet reported Henry Ford Health System 624 participants Est. completion 2020-12-15 1 siteOther conditions: COVID-19, Coronavirus, Coronavirus Infections, SARS-CoV 2View official trial listing → -
Terminated NCT NCT04341727
Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
Not yet reported Washington University School of Medicine 30 participants Est. completion 2021-04-01 2 sitesOther conditions: Coronavirus InfectionView official trial listing → -
Suspended NCT NCT04341870
Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO
Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 27 participants Est. completion 2020-08 5 sites Stand-aloneOther conditions: COVID19, SARS-CoV-2 InfectionView official trial listing → -
Withdrawn NCT NCT04342156
Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19
Not yet reported Tan Tock Seng Hospital Est. completion 2020-10 Stand-aloneOther conditions: Coronavirus Infection, Hydroxychloroquine Adverse ReactionView official trial listing → -
Completed NCT NCT04342169
University of Utah COVID-19 Hydrochloroquine Trial
Not yet reported University of Utah 368 participants Est. completion 2021-11-15 1 site Stand-aloneOther conditions: Coronavirus Infection, Coronavirus, Infectious DiseaseView official trial listing → -
Terminated NCT NCT04342221
Hydroxychloroquine for COVID-19
Not yet reported University Hospital Tuebingen 30 participants Est. completion 2021-02-26 8 sites Stand-aloneOther conditions: COVID-19, Hydroxychloroquine SulfateView official trial listing → -
Completed NCT NCT04343092
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management
Not yet reported University of Baghdad 16 participants Est. completion 2020-06-01 1 site Stand-aloneOther conditions: COVID 19View official trial listing → -
Completed NCT NCT04343768
An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial
Not yet reported Shahid Beheshti University of Medical Sciences 60 participants Est. completion 2020-04-27 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04344379
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
Not yet reported Assistance Publique - Hôpitaux de Paris 122 participants Est. completion 2020-06-18 8 sitesOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Terminated NCT NCT04344444
Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease
Not yet reported LCMC Health 22 participants Est. completion 2022-01-05 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04344457
Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Not yet reported, Not yet reported Perseverance Research Center, LLC 80 participants Est. completion 2020-09-30 2 sitesOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04344951
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
Not yet reported Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. 29 participants Est. completion 2020-11-30 8 sites Stand-aloneOther conditions: Pneumonia, Viral, Covid-19View official trial listing → -
Completed NCT NCT04345159
Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease
Fondation Ophtalmologique Adolphe de Rothschild 572 participants Est. completion 2020-11-30 1 siteOther conditions: SARS-CoV-2, Systemic Lupus Erythematosus, Rheumatoid Arthritis, Sjogren's Syndrome, Psoriatic ArthritisView official trial listing → -
Completed NCT NCT04345653
Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers
Not yet reported Hackensack Meridian Health 48 participants Est. completion 2021-05-10 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Terminated NCT NCT04345692
A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients
Not yet reported Queen's Medical Center 17 participants Est. completion 2020-08-31 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04345861
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
Not yet reported, Not yet reported University Hospital, Montpellier 7 participants Est. completion 2021-04-09 1 site Stand-aloneOther conditions: Coronavirus Infection, Pneumonia, ViralView official trial listing → -
Withdrawn NCT NCT04346329
Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19
Not yet reported Universidad Nacional de Colombia Est. completion 2020-10-30 2 sites Stand-aloneOther conditions: COVIDView official trial listing → -
Terminated NCT NCT04346667
Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds
Not yet reported Government of Punjab, Specialized Healthcare and Medical Education Department 125 participants Est. completion 2020-08-30 3 sites Stand-aloneOther conditions: SARS-CoV-2, Coronavirus Infection, Asymptomatic Condition, COVID-19View official trial listing → -
Completed NCT NCT04346693
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Not yet reported Burnasyan Federal Medical Biophysical Center 320 participants Est. completion 2020-11-20 1 site Stand-aloneOther conditions: Acute Respiratory Tract Infection, Acute Respiratory Insufficiency, Pneumonia, Septic Shock, HypoxemiaView official trial listing → -
Withdrawn NCT NCT04347512
EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA
Not yet reported University Hospital, Strasbourg, France Est. completion 2020-06-02 Stand-aloneOther conditions: Sars-CoV-2, Community-Acquired Pneumonia,COVID-19View official trial listing → -
Completed NCT NCT04347798
IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT
University of Alberta 773 participants Est. completion 2022-06-30 1 siteOther conditions: Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis, HydroxychloroquineView official trial listing → -
Withdrawn NCT NCT04347889
Preventing COVID-19 in Healthcare Workers With HCQ: A RCT
Not yet reported Stony Brook University Est. completion 2020-12-30 Stand-aloneOther conditions: Covid-19View official trial listing → -
Terminated NCT NCT04347980
Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19
Not yet reported Centre Chirurgical Marie Lannelongue 5 participants Est. completion 2020-08-07 1 site Stand-aloneOther conditions: Respiratory Distress Syndrome, Adult, COVID-19View official trial listing → -
Suspended NCT NCT04348474
Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19
Not yet reported Azidus Brasil 200 participants Est. completion 2023-07 1 site Stand-aloneOther conditions: Covid-19View official trial listing → -
Withdrawn NCT NCT04349228
Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals
Not yet reported Abderrahmane Mami Hospital Est. completion 2020-07-15 1 site Stand-aloneOther conditions: COVID19, Sars-CoV2, Hydroxychloroquine, Prophylaxis, Healthcare WorkerView official trial listing → -
Completed NCT NCT04349241
Efficacy and Safety of Favipiravir in Management of COVID-19
Not yet reported Ain Shams University 100 participants Est. completion 2020-06-20 1 siteOther conditions: Coronavirus Disease (COVID-19)View official trial listing → -
Completed NCT NCT04349592
Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19
Not yet reported Hamad Medical Corporation 456 participants Est. completion 2020-08-30 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04350281
Double Therapy With IFN-beta 1b and Hydroxychloroquine
Not yet reported The University of Hong Kong 60 participants Est. completion 2020-07-07 1 siteOther conditions: COVIDView official trial listing → -
Withdrawn NCT NCT04350450
Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore
Not yet reported Montefiore Medical Center Est. completion 2020-08 1 site Stand-aloneOther conditions: COVID, Coronavirus, COVID-19View official trial listing → -
Status unknown NCT NCT04350684
Umifenovir in Hospitalized COVID-19 Patients
Not yet reported Shahid Beheshti University of Medical Sciences 40 participants Est. completion 2020-04-24 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04351516
Test and Treat COVID 65plus+
Not yet reported, Not yet reported University Hospital Tuebingen Est. completion 2021-05-01 2 sites Stand-aloneOther conditions: SARS-CoV 2, COVID-19View official trial listing → -
Completed NCT NCT04351620
High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19
Not yet reported University of Chicago 12 participants Est. completion 2020-06-10 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04351724
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
Not yet reported, Not yet reported Medical University of Vienna 500 participants Est. completion 2022-03-31 9 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04351919
Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
Not yet reported Abderrahmane Mami Hospital Est. completion 2020-07-15 1 site Stand-aloneOther conditions: Patients With COVID19View official trial listing → -
Status unknown NCT NCT04352933
PROLIFIC ChemoprophylaxisTrial (COVID-19)
Not yet reported Cambridge University Hospitals NHS Foundation Trust 1000 participants Est. completion 2021-04 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04352946
HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial
Not yet reported GeoSentinel Foundation 374 participants Est. completion 2020-08-24 1 site Stand-aloneOther conditions: Prophylaxis, COVID-19, Health Care Worker, HydroxychloroquineView official trial listing → -
Terminated NCT NCT04353037
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine
Not yet reported UnitedHealth Group 39 participants Est. completion 2020-07-11 1 siteOther conditions: Coronavirus, Corona Virus InfectionView official trial listing → -
Status unknown NCT NCT04353180
Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)
Not yet reported Kafrelsheikh University 100000 participants Est. completion 2021-11 2 sitesOther conditions: COVID19View official trial listing → -
Status unknown NCT NCT04353245
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
University of Sao Paulo General Hospital 130 participants Est. completion 2021-09-30 1 siteOther conditions: COVID19, Corona Virus Infection, Myocardial Injury, PneumoniaView official trial listing → -
Terminated NCT NCT04353271
Trial of Hydroxychloroquine In Covid-19 Kinetics
Not yet reported, Not yet reported University of South Alabama 3 participants Est. completion 2020-07-08 1 site Stand-aloneOther conditions: Covid 19, Corona Virus InfectionView official trial listing → -
Terminated NCT NCT04354428
Treatment for COVID-19 in High-Risk Adult Outpatients
Not yet reported, Not yet reported University of Washington 289 participants Est. completion 2020-11-30 6 sites Stand-aloneOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Withdrawn NCT NCT04354441
Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women
Not yet reported Sir Mortimer B. Davis - Jewish General Hospital Est. completion 2020-05 Stand-aloneOther conditions: COVID-19, SARS-CoV-2, Pregnant Women, HydroxychloroquineView official trial listing → -
Withdrawn NCT NCT04354597
Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients
Not yet reported King Hussein Cancer Center Est. completion 2020-10-15 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04354870
COVID-19 PrEP HCW HCQ Study
Not yet reported NYU Langone Health 130 participants Est. completion 2020-10-01 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04355026
Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia
Not yet reported General and Teaching Hospital Celje 90 participants Est. completion 2020-07-31 1 site Stand-aloneOther conditions: Covid-19View official trial listing → -
Status unknown NCT NCT04355052
Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus
Not yet reported Sheba Medical Center 250 participants Est. completion 2020-12-11 2 sites Stand-aloneOther conditions: COVID - 19View official trial listing → -
Completed NCT NCT04355702
Covid-19 in Lupus Patients
University Hospital, Montpellier 130 participants Est. completion 2020-12-30 1 siteOther conditions: Systemic Lupus Erythematosus, Covid-19View official trial listing → -
Terminated NCT NCT04358068
Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2020-07-08 11 sites Stand-aloneOther conditions: COVID-19, SARS-CoV 2View official trial listing → -
Completed NCT NCT04358081
Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease
Not yet reported Novartis Pharmaceuticals 20 participants Est. completion 2020-07-27 7 sites Stand-aloneOther conditions: Covid-19View official trial listing → -
Completed NCT NCT04358302
Individual Patient Exposure and Response in Pediatric Lupus
Not yet reported Duke University 26 participants Est. completion 2021-06-16 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT04359537
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
Not yet reported Shaheed Zulfiqar Ali Bhutto Medical University 200 participants Est. completion 2020-09-25 1 site Stand-aloneOther conditions: COVID 19View official trial listing → -
Status unknown NCT NCT04359615
Favipiravir in Hospitalized COVID-19 Patients
Not yet reported Shahid Beheshti University of Medical Sciences 40 participants Est. completion 2020-05-05 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04359667
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
University Hospital for Infectious Diseases, Croatia 30 participants Est. completion 2021-05-15 1 siteOther conditions: COVID-19, Severe PneumoniaView official trial listing → -
Terminated NCT NCT04359953
Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19
Not yet reported University Hospital, Strasbourg, France 16 participants Est. completion 2022-06-01 1 site Stand-aloneOther conditions: COVID-19 InfectionView official trial listing → -
Withdrawn NCT NCT04360759
Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19
Not yet reported University of Cape Town Est. completion 2021-06-30 2 sites Stand-aloneOther conditions: Covid-19, HIVView official trial listing → -
Status unknown NCT NCT04361318
Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19
Not yet reported, Not yet reported Tanta University 100 participants Est. completion 2020-12 Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04362332
Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19
Not yet reported UMC Utrecht 25 participants Est. completion 2020-06-08 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04363450
Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)
Not yet reported Louisiana State University Health Sciences Center in New Orleans 1700 participants Est. completion 2021-06-01 2 sites Stand-aloneOther conditions: COVID-19, Corona Virus Infection, Wuhan Coronavirus, Prophylaxis, Healthcare Worker, Sars-CoV2, HydroxychloroquineView official trial listing → -
Terminated NCT NCT04363827
Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)
Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 155 participants Est. completion 2021-09-30 1 site Stand-aloneOther conditions: COVID19, Hydroxychloroquine, Prophylaxis, Treatment, SARS-CoV-2View official trial listing → -
Withdrawn NCT NCT04363866
Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)
Not yet reported Oregon Health and Science University Est. completion 2021-09 1 site Stand-aloneOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Withdrawn NCT NCT04364815
The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial
Not yet reported University of the Philippines Est. completion 2021-05 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04365231
Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial
Not yet reported Hospital St. Joseph, Marseille, France Est. completion 2021-04-01 Stand-aloneOther conditions: COVID19View official trial listing → -
Status unknown NCT NCT04366089
Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora
Not yet reported Roberto Poscia MD, PhD 152 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: COVID, SARS-CoV 2, Pneumonia, Viral, Coronavirus InfectionView official trial listing → -
Status unknown NCT NCT04368351
Bacteriotherapy in the Treatment of COVID-19
University of Roma La Sapienza 70 participants Est. completion 2020-07-31 1 siteOther conditions: COVID, Pneumonia, DiarrheaView official trial listing → -
Terminated NCT NCT04369742
Treating COVID-19 With Hydroxychloroquine (TEACH)
Not yet reported NYU Langone Health 128 participants Est. completion 2021-04-01 2 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04369989
Observational Study of COVID-19 Treatment Efficacy
OSF Healthcare System 250 participants Est. completion 2021-04-14 1 siteOther conditions: Coronavirus, Coronavirus Infection, Corona Virus Infection, COVID, Sars-CoV2, Coronavirus as the Cause of Diseases Classified Elsewhere, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere, COVID-19, Coronavirus Disease, Coronavirus Sars-Associated as Cause of Disease Classified ElsewhereView official trial listing → -
Completed NCT NCT04370782
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
Not yet reported St. Francis Hospital, New York 18 participants Est. completion 2020-09-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04371406
Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients
Not yet reported Assistance Publique - Hôpitaux de Paris Est. completion 2020-09 Stand-aloneOther conditions: Covid-19View official trial listing → -
Withdrawn NCT NCT04371523
Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers
Not yet reported St. Joseph's Healthcare Hamilton Est. completion 2020-08-30 1 site Stand-aloneOther conditions: Corona Virus InfectionView official trial listing → -
Completed NCT NCT04371744
QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19
Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2020-06-05 1 siteOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04371926
Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk
Not yet reported Texas Cardiac Arrhythmia Research Foundation Est. completion 2021-07Other conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04372082
Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19
Not yet reported University Hospital, Lille Est. completion 2023-05 Stand-aloneOther conditions: Sars-CoV2View official trial listing → -
Terminated NCT NCT04373044
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
Not yet reported University of Southern California 6 participants Est. completion 2021-05-12 2 sites Stand-aloneOther conditions: Symptomatic COVID-19 Infection Laboratory-ConfirmedView official trial listing → -
Completed NCT NCT04374071
Early Short Course Corticosteroids in COVID-19
Henry Ford Health System 250 participants Est. completion 2020-04-30 1 siteOther conditions: COVID, Pneumonia, ViralView official trial listing → -
Terminated NCT NCT04374539
Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
Not yet reported Fundacion Clinic per a la Recerca Biomédica 36 participants Est. completion 2021-06-29 1 site Stand-aloneOther conditions: CoronavirusView official trial listing → -
Withdrawn NCT NCT04374552
Asymptomatic COVID-19 Trial
Not yet reported Rutgers, The State University of New Jersey Est. completion 2021-04 1 site Stand-aloneOther conditions: SARS-CoV-2 InfectionView official trial listing → -
Withdrawn NCT NCT04374903
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients
Not yet reported King Hussein Cancer Center Est. completion 2022-04-01 1 site Stand-aloneOther conditions: COVID-19 PatientsView official trial listing → -
Terminated NCT NCT04374942
Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?
Not yet reported Megan Landes 13 participants Est. completion 2021-03-31 1 site Stand-aloneOther conditions: Pre-Exposure Prophylaxis, Coronavirus, SARS-CoV 2View official trial listing → -
Completed NCT NCT04376814
Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19
Not yet reported Baqiyatallah Medical Sciences University 40 participants Est. completion 2020-05-25 1 site Stand-aloneOther conditions: COVID-19, Favipiravir, Kaletra, Hydroxychloroquine, Lopinavir/RitonavirView official trial listing → -
Status unknown NCT NCT04377646
A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
Not yet reported Military Hospital of Tunis 660 participants Est. completion 2020-07-31 1 siteOther conditions: Sars-CoV2, COVID19View official trial listing → -
Withdrawn NCT NCT04379492
A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2020-09-25 1 site Stand-aloneOther conditions: COVID-19, COVID19, Sars-CoV2, SARS-Cov-2View official trial listing → -
Status unknown NCT NCT04380818
Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19
Not yet reported Grupo de Investigación Clínica en Oncología Radioterapia 106 participants Est. completion 2021-11-01 3 sites Stand-aloneOther conditions: Pneumonia, ViralView official trial listing → -
Terminated NCT NCT04381988
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy
Not yet reported Memorial Sloan Kettering Cancer Center 4 participants Est. completion 2021-04-21 7 sites Stand-aloneOther conditions: COVID-19, CancerView official trial listing → -
Withdrawn NCT NCT04382625
Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
Not yet reported Kootenai Health Est. completion 2022-06-01 1 site Stand-aloneOther conditions: SARS-CoV-2 Pneumonia, COVID-19View official trial listing → -
Status unknown NCT NCT04383717
Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
Not yet reported Cairo University 60 participants Est. completion 2020-10-30Other conditions: Respiratory Tract InfectionsView official trial listing → -
Completed NCT NCT04386057
LY3214996 +/- HCQ in Pancreatic Cancer
Not yet reported Kimberly Perez, MD 52 participants Est. completion 2024-02-05 4 sites Stand-aloneOther conditions: Pancreatic Cancer, Advanced CancerView official trial listing → -
Withdrawn NCT NCT04386239
Study on the Use of Sarilumab in Patients With COVID-19 Infection
Not yet reported ASST Fatebenefratelli Sacco Est. completion 2023-01-01 1 site Stand-aloneOther conditions: COVID19View official trial listing → -
Completed NCT NCT04387760
Favipiravir vs Hydroxychloroquine vs Control in COVID -19
Not yet reported Royal College of Surgeons in Ireland - Medical University of Bahrain 150 participants Est. completion 2021-04-07 1 site Stand-aloneOther conditions: SARS-CoV 2, COVID-19View official trial listing → -
Completed NCT NCT04389320
Antimalarial and Covid 19 in Rheumatoid Arthritis
Assiut University 60 participants Est. completion 2020-05-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Withdrawn NCT NCT04389359
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
Not yet reported, Not yet reported Cambridge University Hospitals NHS Foundation Trust Est. completion 2025-08 Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04390061
TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia
Not yet reported Università Politecnica delle Marche 116 participants Est. completion 2020-10 Stand-aloneOther conditions: Pneumonitis, Interstitial, COVID-19View official trial listing → -
Completed NCT NCT04391127
Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
Not yet reported Centenario Hospital Miguel Hidalgo 108 participants Est. completion 2020-11-06 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04392128
Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)
Not yet reported Institut de cancérologie Strasbourg Europe Est. completion 2020-09-02 1 site Stand-aloneOther conditions: COVID19, Hematologic MalignancyView official trial listing → -
Status unknown NCT NCT04394442
Hydroxychloroquine in COVID-19 Patients
Not yet reported Samah Lutfy 200 participants Est. completion 2020-08 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04395170
Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.
Not yet reported, Not yet reported Lifefactors Zona Franca, SAS 75 participants Est. completion 2021-06 1 siteOther conditions: Coronavirus Disease 2019 (COVID-19)View official trial listing → -
Status unknown NCT NCT04395768
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
Not yet reported National Institute of Integrative Medicine, Australia 200 participants Est. completion 2021-12-31 1 site Stand-aloneOther conditions: COVID19View official trial listing → -
Withdrawn NCT NCT04397328
COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Est. completion 2021-04-30 Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04400019
Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
Not yet reported, Not yet reported University of Malaga 1930 participants Est. completion 2021-04-01 Stand-aloneOther conditions: Sars-CoV2, Coronavirus Infection, Prevention & Control, Nursing Home, HydroxychloroquineView official trial listing → -
Status unknown NCT NCT04403100
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"
Not yet reported Cardresearch 1968 participants Est. completion 2021-02-01 4 sitesOther conditions: COVID-19, Coronavirus Infection, Virus Disease, Acute Respiratory Infection, SARS-CoV InfectionView official trial listing → -
Terminated NCT NCT04403646
Tannin Specific Natural Extract for COVID-19 Infection
Not yet reported Hospital de Clinicas José de San Martín 124 participants Est. completion 2020-11-01 1 site Stand-aloneOther conditions: COVID-19, SARS-CoV 2, Coronavirus InfectionView official trial listing → -
Status unknown NCT NCT04405921
Hydroxychloroquine, Azithromycin in the Treatment of Covid-19
Not yet reported Centre Hôpital Universitaire Farhat Hached 200 participants Est. completion 2021-03 1 site Stand-aloneOther conditions: SARS-CoV-2 Pneumonia, COVID-19View official trial listing → -
Status unknown NCT NCT04410510
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
Not yet reported, Not yet reported Hospital Universitario San Ignacio 100 participants Est. completion 2021-11-30 1 site Stand-aloneOther conditions: COVID, Coronavirus Infection, SARS-CoV 2, COVID19View official trial listing → -
Completed NCT NCT04410562
Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum
Not yet reported Barcelona Institute for Global Health 129 participants Est. completion 2021-10-31 9 sites Stand-aloneOther conditions: Pregnancy Related, COVID, Covid-19View official trial listing → -
Status unknown NCT NCT04411433
Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19
Not yet reported Ministry of Health, Turkey 1008 participants Est. completion 2021-06-01 1 site Stand-aloneOther conditions: Sars-CoV2, COVID-19View official trial listing → -
Completed NCT NCT04414241
Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19
Not yet reported Universidad Peruana Cayetano Heredia 68 participants Est. completion 2020-11-23 3 sites Stand-aloneOther conditions: SARS-CoV-2View official trial listing → -
Withdrawn NCT NCT04418193
Patient Preference Trial for COVID-19 (PPT-COVID)
Centre Hospitalier Princesse Grace Est. completion 2021-02-04 1 siteOther conditions: CoronavirusView official trial listing → -
Completed NCT NCT04420247
Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
Not yet reported Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva 142 participants Est. completion 2020-09-03 1 site Stand-aloneOther conditions: COVID, COVID-19, SARS-CoV 2, Coronavirus, Corona Virus InfectionView official trial listing → -
Terminated NCT NCT04421664
Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 70 participants Est. completion 2020-08-17 8 sites Stand-aloneOther conditions: Corona Virus Infection, SARS-CoV Infection, CoronavirusView official trial listing → -
Completed NCT NCT04434144
A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar 116 participants Est. completion 2020-06-05 1 siteOther conditions: Ivermectin, Hydroxychloroquine, COVID19View official trial listing → -
Status unknown NCT NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
Not yet reported, Not yet reported Chromis LLC 330 participants Est. completion 2020-07 22 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04435587
Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection
Not yet reported Mahidol University 80 participants Est. completion 2021-11 4 sitesOther conditions: Asymptomatic Infections, SARS-CoV2 InfectionView official trial listing → -
Status unknown NCT NCT04438837
Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers
Not yet reported Rambam Health Care Campus 582 participants Est. completion 2022-06 1 siteOther conditions: Coronavirus Disease 2019 (COVID-19), Post-Exposure ProphylaxisView official trial listing → -
Status unknown NCT NCT04443725
Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
Not yet reported, Not yet reported Cairo University 100 participants Est. completion 2020-12 Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04446104
A Preventive Treatment for Migrant Workers at High-risk of COVID-19
Not yet reported National University Hospital, Singapore 4257 participants Est. completion 2020-08-31 1 site Stand-aloneOther conditions: Covid-19View official trial listing → -
Completed NCT NCT04447534
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19
Not yet reported Tanta University 191 participants Est. completion 2020-08-15 1 site Stand-aloneOther conditions: COVIDView official trial listing → -
Completed NCT NCT04452617
Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19
Institut Mutualiste Montsouris 40 participants Est. completion 2020-07-01 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04453501
Anti Infective Agents Impact in COVID-19 Pneumonia
Centre d'Investigation Clinique et Technologique 805 132 participants Est. completion 2020-04-25 1 siteOther conditions: COVID, Pneumonia, ViralView official trial listing → -
Completed NCT NCT04454372
Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)
Hospital Sao Domingos 187 participants Est. completion 2020-11-30 1 siteOther conditions: COVID-19View official trial listing → -
Terminated NCT NCT04458948
Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients
Not yet reported University of New Mexico 28 participants Est. completion 2020-08-28 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04459702
A Study of Combination Therapies to Treat COVID-19 Infection
Not yet reported ProgenaBiome Est. completion 2021-12 1 site Stand-aloneOther conditions: COVID, COVID-19, Corona Virus Infection, Coronavirus Infection, Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere, Coronavirus-19, SARS-CoV 2, SARS PneumoniaView official trial listing → -
Status unknown NCT NCT04460547
Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic
Qassim University 200 participants Est. completion 2020-09-20Other conditions: COVID-19View official trial listing → -
Completed NCT NCT04461353
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers
Not yet reported Pulmoquine Therapeutics, Inc 12 participants Est. completion 2020-08-17 1 siteOther conditions: Severe Acute Respiratory Syndrome Coronavirus 2View official trial listing → -
Status unknown NCT NCT04463420
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19
Not yet reported Baqiyatallah Medical Sciences University 224 participants Est. completion 2020-12-15 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT04464759
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Not yet reported, Not yet reported Ravi Amaravadi, MD 41 participants Est. completion 2027-05-12 1 site Stand-aloneOther conditions: MelanomaView official trial listing → -
Completed NCT NCT04466540
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)
Not yet reported Hospital Alemão Oswaldo Cruz 1372 participants Est. completion 2021-09-28 69 sites Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04475120
Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients
Not yet reported, Not yet reported University of Rome Tor Vergata 92 participants Est. completion 2020-07-02 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04475588
Efficacy and Safety of Itolizumab in COVID-19 Complications
Not yet reported Biocon Limited 32 participants Est. completion 2020-07-07 4 sites Stand-aloneOther conditions: Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Covid19View official trial listing → -
Status unknown NCT NCT04477083
Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19
Not yet reported Mansoura University 40 participants Est. completion 2020-08-15 1 siteOther conditions: Covid19, Hydroxychloroquine Adverse ReactionView official trial listing → -
Completed NCT NCT04491994
Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression
Not yet reported UNICEF 540 participants Est. completion 2020-05-31 1 siteOther conditions: Covid19, ProgressionView official trial listing → -
Completed NCT NCT04497519
Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers
Not yet reported University Medical Center Groningen 12 participants Est. completion 2020-11-01 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04501783
Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
Not yet reported R-Pharm 168 participants Est. completion 2020-08-04 10 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04501965
Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients
Not yet reported Institute for Research and Development of Medicinal and Food Plants of Guinea 231 participants Est. completion 2020-09-30 1 siteOther conditions: Covid19View official trial listing → -
Terminated NCT NCT04522466
Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 7 participants Est. completion 2020-05-28 4 sites Stand-aloneOther conditions: Sars-CoV2View official trial listing → -
Completed NCT NCT04524702
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
Not yet reported Emory University 10 participants Est. completion 2023-06-06 3 sites Stand-aloneOther conditions: Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8View official trial listing → -
Withdrawn NCT NCT04528927
Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
Not yet reported Abderrahmane Mami Hospital Est. completion 2020-07-15 1 site Stand-aloneOther conditions: COVID 19, Patients HospitalizedView official trial listing → -
Completed NCT NCT04530422
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
Not yet reported Almaza Military Fever Hospital 250 participants Est. completion 2020-07-23 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04546542
Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients
University of Sao Paulo General Hospital 74 participants Est. completion 2024-02-22 2 sitesOther conditions: Sjogren's SyndromeView official trial listing → -
Completed NCT NCT04554979
COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience
Cairo University 199 participants Est. completion 2020-07-15 1 siteOther conditions: Covid19, DiarrheaView official trial listing → -
Status unknown NCT NCT04569890
Treatment of Pregnancy RA
Not yet reported RenJi Hospital 100 participants Est. completion 2023-12-01 1 siteOther conditions: Rheumatoid Arthritis, Pregnancy RelatedView official trial listing → -
Terminated NCT NCT04573153
Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
Not yet reported, Not yet reported ScandiBio Therapeutics AB 100 participants Est. completion 2022-05-05 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04575558
HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19
Not yet reported Latin American Cooperative Oncology Group Est. completion 2020-10-30 7 sites Stand-aloneOther conditions: Sars-CoV2View official trial listing → -
Withdrawn NCT NCT04590274
Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Not yet reported International Brain Research Foundation Est. completion 2021-12 Stand-aloneOther conditions: Covid19, SARS (Severe Acute Respiratory Syndrome)View official trial listing → -
Completed NCT NCT04593758
To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue
Not yet reported, Not yet reported Cornerstone Pharmaceuticals 16 participants Est. completion 2023-03-09 8 sites Stand-aloneOther conditions: Sarcoma, Clear CellView official trial listing → -
Terminated NCT NCT04605588
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
Not yet reported Rutgers, The State University of New Jersey 7 participants Est. completion 2021-02-04 1 siteOther conditions: SARS-CoV Infection, Covid19View official trial listing → -
Status unknown NCT NCT04624269
A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome
Not yet reported Shanghai First Maternity and Infant Hospital 384 participants Est. completion 2023-02-01 1 site Stand-aloneOther conditions: Antiphospholipid Syndrome, Recurrent MiscarriageView official trial listing → -
Completed NCT NCT04646109
Ivermectin for Severe COVID-19 Management
Not yet reported Afyonkarahisar Health Sciences University 66 participants Est. completion 2020-09-02 4 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04668469
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
Not yet reported Benha University 600 participants Est. completion 2020-10-30 1 siteOther conditions: Covid19View official trial listing → -
Completed NCT NCT04691505
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine
Brigham and Women's Hospital 133553 participants Est. completion 2021-08-31 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04697654
The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers
Not yet reported Taiwan Liposome Company 30 participants Est. completion 2021-06-18 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04712279
The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)
Not yet reported, Not yet reported Corpometria Institute 294 participants Est. completion 2021-04-20Other conditions: Covid19View official trial listing → -
Status unknown NCT NCT04715295
Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19
Not yet reported Yaounde Central Hospital 200 participants Est. completion 2021-09-05 1 siteOther conditions: COVID-19View official trial listing → -
Withdrawn NCT NCT04731051
The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients
Not yet reported, Not yet reported King Hussein Cancer Center Est. completion 2022-12 1 site Stand-aloneOther conditions: 2019 Novel CoronavirusView official trial listing → -
Completed NCT NCT04735068
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Non-Small Cell Lung Cancer, KRAS Mutation-Related TumorsView official trial listing → -
Completed NCT NCT04746365
Ivermectin Role in Covid-19 Clinical Trial
Not yet reported Elaraby Hospital 300 participants Est. completion 2021-02-06 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04755322
Hydroxychloroquine in Prevention of Preeclampsia
Not yet reported Assiut University 50 participants Est. completion 2023-07-30 1 siteOther conditions: PreeclampsiaView official trial listing → -
Completed NCT NCT04760080
Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.
Hospices Civils de Lyon 31 participants Est. completion 2020-10-01 1 siteOther conditions: Dermatology and OncologyView official trial listing → -
Status unknown NCT NCT04779047
Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
Not yet reported October 6 University 150 participants Est. completion 2021-04-05 1 siteOther conditions: Covid19, PneumoniaView official trial listing → -
Completed NCT NCT04787991
Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Not yet reported Cancer Insight, LLC 45 participants Est. completion 2025-07-31 6 sites Stand-aloneOther conditions: Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT04788355
Prevention of Complications (SARS-CoV-2): Clinical Study
Not yet reported Universidade do Vale do Sapucai 176 participants Est. completion 2020-12-23 1 site Stand-aloneOther conditions: ComplicationView official trial listing → -
Terminated NCT NCT04809623
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
Not yet reported Gilead Sciences 3 participants Est. completion 2022-10-18 5 sites Stand-aloneOther conditions: Cutaneous Lupus ErythematosusView official trial listing → -
Completed NCT NCT04812496
Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)
Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud 100 participants Est. completion 2021-01-15 1 siteOther conditions: Covid19, SARS-CoV Infection, TenofovirView official trial listing → -
Active, not recruiting NCT NCT04841148
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 96 participants Est. completion 2028-05 7 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04853901
Remdesivir Efficacy In Management Of COVID-19 Patients
Not yet reported Ain Shams University 77 participants Est. completion 2021-03-01 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04858633
Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 1000 participants Est. completion 2021-06-30 1 siteOther conditions: Covid19, COVID-19 PreventionView official trial listing → -
Status unknown NCT NCT04860284
Hydroxychloroquine for Treatment of Non-Severe COVID-19
Not yet reported Makerere University 105 participants Est. completion 2021-12-01 1 siteOther conditions: Covid19View official trial listing → -
Terminated NCT NCT04873895
TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)
Not yet reported Abramson Cancer Center at Penn Medicine 5 participants Est. completion 2024-04-25 1 site Stand-aloneOther conditions: Colorectal Neoplasms MalignantView official trial listing → -
Status unknown NCT NCT04904692
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
University Hospital, Ghent 109 participants Est. completion 2024-09-30 3 sitesOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04932889
Musculoskeletal Symptoms in Post Acute Covid-19 Patients
Eskisehir City Hospital 280 participants Est. completion 2021-06-14 1 siteOther conditions: Covid19, Musculoskeletal AbnormalitiesView official trial listing → -
Completed NCT NCT04933864
COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy
Not yet reported I.M. Sechenov First Moscow State Medical University 60 participants Est. completion 2020-07-30 1 site Stand-aloneOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT04937907
Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
Not yet reported Shanghai Children's Hospital 50 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Alport Syndrome, X-LinkedView official trial listing → -
Status unknown NCT NCT04954040
Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
Not yet reported Maimónides Biomedical Research Institute of Córdoba 132 participants Est. completion 2021-12 1 site Stand-aloneOther conditions: Acute Respiratory Distress Syndrome, Covid19View official trial listing → -
Status unknown NCT NCT04964583
Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19
Not yet reported, Not yet reported Coordinación de Investigación en Salud, Mexico 105 participants Est. completion 2021-08 3 sites Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04973566
A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants
Not yet reported Janssen Research & Development, LLC 48 participants Est. completion 2022-05-27 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04981145
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 78 participants Est. completion 2025-07 1 siteOther conditions: Primary Sjögren's SyndromeView official trial listing → -
Completed NCT NCT04981379
Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment
Not yet reported Health Institutes of Turkey 1120 participants Est. completion 2021-02-16 6 sitesOther conditions: Covid19View official trial listing → -
Completed NCT NCT05016297
Efficacy and Safety of Baricitinib in Sjogren's Syndrome
Not yet reported Peking Union Medical College Hospital 87 participants Est. completion 2024-11-22 1 siteOther conditions: Sjogren's SyndromeView official trial listing → -
Completed NCT NCT05024006
Public Health Emergency: SOLIDARITY TRIAL Philippines
Not yet reported University of the Philippines 1314 participants Est. completion 2021-04-17 25 sites Stand-aloneOther conditions: Covid19View official trial listing → -
Withdrawn NCT NCT05026801
Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
Not yet reported Iterum Therapeutics, International Limited Est. completion 2021-08-26 1 siteOther conditions: Respiratory Tract Infection ViralView official trial listing → -
Completed NCT NCT05051137
Real-World Emulation of the SWEFOT Trial
Karolinska Institutet 509 participants Est. completion 2020-11-16 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Active, not recruiting NCT NCT05083780
Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer
Not yet reported Changhoon Yoo 40 participants Est. completion 2026-12-30 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT05084872
Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients
Not yet reported, Not yet reported University Hospital, Toulouse 30 participants Est. completion 2024-01 1 site Stand-aloneOther conditions: MastocytosisView official trial listing → -
Withdrawn NCT NCT05110651
The Danish Pre-HCQ COVID Dialysis Study
Not yet reported Nicholas Carlson Est. completion 2020-10-01 3 sitesOther conditions: COVID-19, End Stage Renal DiseaseView official trial listing → -
Status unknown NCT NCT05113810
The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
Not yet reported Ministry of Health Jordan 110 participants Est. completion 2022-07-20 1 site Stand-aloneOther conditions: 2019 Novel CoronavirusView official trial listing → -
Completed NCT NCT05118984
Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes
Not yet reported Cairo University 324 participants Est. completion 2021-10-04 2 sitesOther conditions: Meconium Stained, Azithromycin, Postpartum EndometritisView official trial listing → -
Active, not recruiting NCT NCT05119140
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis
Not yet reported, Not yet reported Icahn School of Medicine at Mount Sinai 3 participants Est. completion 2025-05 2 sites Stand-aloneOther conditions: Ulcerative Colitis (Disorder)View official trial listing → -
Active, not recruiting NCT NCT05126147
Hydroxychloroquine in Mild Graves' Orbitopathy
Not yet reported National Taiwan University Hospital 108 participants Est. completion 2027-06-30 2 sites Stand-aloneOther conditions: Graves OphthalmopathyView official trial listing → -
Terminated NCT NCT05221320
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
Not yet reported BioMed Valley Discoveries, Inc 47 participants Est. completion 2024-07-14 9 sites Stand-aloneOther conditions: Tumor, Solid, Gastrointestinal CancerView official trial listing → -
Status unknown NCT NCT05247554
Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis
Not yet reported Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2024-03-01 Stand-aloneOther conditions: Pulmonary SarcoidosisView official trial listing → -
Active, not recruiting NCT NCT05279027
Zr89 + PET Companion Trial
Not yet reported Abramson Cancer Center at Penn Medicine 6 participants Est. completion 2027-05-12 1 siteOther conditions: Melanoma (Skin)View official trial listing → -
Terminated NCT NCT05306353
CD40L Antagonism in Rheumatoid Arthritis (RA)
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2025-07-28 5 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT05311813
Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19
Not yet reported Beni-Suef University 200 participants Est. completion 2021-12-30 1 siteOther conditions: COVID-19 PandemicView official trial listing → -
Active, not recruiting NCT NCT05365893
PHL Treatment in Pancreatic Cancer
Not yet reported Fox Chase Cancer Center 20 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Completed NCT NCT05447520
Montelukast Use in Rheumatoid Arthritis
Not yet reported Noha Mansour 92 participants Est. completion 2022-12-30 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT05518110
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Not yet reported Cancer Trials Ireland 20 participants Est. completion 2026-03-03 2 sites Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT05576896
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
Not yet reported Northwestern University 7 participants Est. completion 2026-04-20 1 site Stand-aloneOther conditions: Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IVView official trial listing → -
Status unknown NCT NCT05644210
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Qilu Hospital of Shandong University 80 participants Est. completion 2025-12-30 1 siteOther conditions: Antiphospholipid SyndromeView official trial listing → -
Status unknown NCT NCT05647330
Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer
Not yet reported Henan Cancer Hospital 55 participants Est. completion 2025-10-01 Stand-aloneOther conditions: Hydroxychloroquine, Gemcitabine, Lung NeoplasmsView official trial listing → -
Status unknown NCT NCT05651373
The Clinical Features and Pregnancy Outcomes of RA Patients
Qilu Hospital of Shandong University 100 participants Est. completion 2024-12-31 1 siteOther conditions: Rheumatoid Arthritis, Pregnancy RelatedView official trial listing → -
Status unknown NCT NCT05666336
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Not yet reported Fen Li 30 participants Est. completion 2024-06-30 1 site Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT05670535
Sjögren and Gynecologic Considerations
Ankara City Hospital Bilkent 118 participants Est. completion 2022-11-10 1 siteOther conditions: Primary Sjögren Syndrome, Vaginitis Candida, Vaginitis, Sexual DysfunctionView official trial listing → -
Completed NCT NCT05671497
The Effect of Cilostazol on Rheumatoid Arthritis Patients
Not yet reported, Not yet reported Ain Shams University 70 participants Est. completion 2024-10-01 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT05678335
Tacrolimus for Thrombocytopenia in SS
Not yet reported, Not yet reported Peking Union Medical College Hospital 54 participants Est. completion 2024-03Other conditions: Sjogren Syndrome With Other Organ InvolvementView official trial listing → -
Withdrawn NCT NCT05689359
Evaluation of Hydroxychloroquine to Prevent CIPN
Not yet reported University of Arizona Est. completion 2025-12-01 Stand-aloneOther conditions: Breast Cancer, Gynecologic Cancer, Early-stage Breast Cancer, Peripheral Neuropathy, Chemotherapy-induced Peripheral NeuropathyView official trial listing → -
Completed NCT NCT05714670
The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis
Not yet reported Ain Shams University 72 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Lupus Nephritis, SLE NephritisView official trial listing → -
Status unknown NCT NCT05733897
Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis
National Taiwan University Hospital 150 participants Est. completion 2025-07-01 2 sitesMASHView official trial listing → -
Completed NCT NCT05819918
Calcifediol in the Treatment of COVID 19
Maimónides Biomedical Research Institute of Córdoba 728 participants Est. completion 2023-04-17 1 siteOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT05843188
Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
Not yet reported University Health Network, Toronto 155 participants Est. completion 2026-12-24 2 sites Stand-aloneOther conditions: Metastatic Colorectal CancerView official trial listing → -
Terminated NCT NCT05942911
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
Not yet reported Incannex Healthcare Ltd 20 participants Est. completion 2025-10-28 10 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT05961202
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
Not yet reported, Not yet reported Tongji Hospital 200 participants Est. completion 2025-11-01 1 site Stand-aloneOther conditions: Inflammatory Cardiomyopathy, MyocarditisView official trial listing → -
Active, not recruiting NCT NCT06020378
Hydroxychloroquine May be Beneficial for Preeclampsia
RenJi Hospital 462 participants Est. completion 2026-12-01 1 siteOther conditions: Pre-EclampsiaView official trial listing → -
Completed NCT NCT06083688
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi
Not yet reported Liverpool School of Tropical Medicine 788 participants Est. completion 2026-01-14 1 siteOther conditions: Malaria,Falciparum, Anemia in ChildrenView official trial listing → -
Completed NCT NCT06161363
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
University Hospital, Toulouse 102 participants Est. completion 2024-12-16 1 siteOther conditions: Lupus ErythematosusView official trial listing → -
Completed NCT NCT06223984
Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients
Not yet reported Konya City Hospital 178 participants Est. completion 2020-11-14 1 siteOther conditions: Pulse Steroid and Immunoglobulins Drugs in Covid 19 PatientsView official trial listing → -
Status unknown NCT NCT06229340
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Not yet reported N.N. Petrov National Medical Research Center of Oncology 20 participants Est. completion 2026-10-01 1 site Stand-aloneOther conditions: RAS Mutation, Ras (Kras or Nras) Gene Mutation, Colorectal Cancer Recurrent, Pancreas Cancer, Lung Cancer, Melanoma, Refractory CancerView official trial listing → -
Completed NCT NCT06319560
Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Not yet reported National University of Malaysia 56 participants Est. completion 2026-06-01 1 site Stand-aloneType 2 diabetes Other conditions: Diabetes in PregnancyView official trial listing → -
Status unknown NCT NCT06328387
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
Not yet reported, Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120 participants Est. completion 2026-03-01 1 site Stand-aloneOther conditions: Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06432101
Acupuncture Combined With Hydroxychloroquine
Not yet reported Senyue Zhang 65 participants Est. completion 2023-12-31 1 siteOther conditions: Primary Sjögren's SyndromeView official trial listing → -
Status unknown NCT NCT06512753
The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical Care: a Patient Preference Trial
Erasmus Medical Center 56 participants Est. completion 2026-07-01 1 siteOther conditions: Lichen Planopilaris, Cicatricial AlopeciaView official trial listing → -
Completed NCT NCT06512766
a Retrospective Study on the Systemic Treatment of LPP and FFA
Erasmus Medical Center 315 participants Est. completion 2023-02-01 1 siteOther conditions: Cicatricial Alopecia, Lichen Planopilaris, Lichen Plano-Pilaris, Frontal Fibrosing Alopecia, Hair Diseases, Scarring Alopecia, Hair Loss/BaldnessView official trial listing → -
Enrolling by invitation NCT NCT06519617
Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage
Not yet reported Qingwen Tao 136 participants Est. completion 2026-12-31 1 siteOther conditions: Primary Sjögren SyndromeView official trial listing → -
Completed NCT NCT06776445
Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial
Not yet reported First Affiliated Hospital of Chongqing Medical University 50 participants Est. completion 2025-07-31 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Active, not recruiting NCT NCT06816810
A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease
Not yet reported Ottawa Hospital Research Institute 40 participants Est. completion 2027-09 1 site Stand-aloneOther conditions: Parkinson&Amp;#39;s DiseaseView official trial listing → -
Completed NCT NCT06839443
Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy
Centro Hospitalar de Lisboa Central 100 participants Est. completion 2026-09-20 1 siteOther conditions: Hidroxicloroquine IntakeView official trial listing → -
Not yet recruiting NCT NCT06862284
Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
Not yet reported Peking University People's Hospital 30 participants Est. completion 2027-08-31 1 siteOther conditions: Primary Sjögren's Syndrome (pSS)View official trial listing → -
Not yet recruiting NCT NCT07061717
Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 474 participants Est. completion 2029-07-01 1 site Stand-aloneOther conditions: Hormone Receptor-Positive and HER2-Negative Advanced Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07190534
The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)
Erasmus Medical Center 50 participants Est. completion 2027-05 1 siteOther conditions: Frontal Fibrosing Alopecia, Cicatricial AlopeciaView official trial listing → -
Not yet recruiting NCT NCT07294872
A Study of TIL in Advanced Solid Tumors (CZ)
Not yet reported Shanghai Juncell Therapeutics 30 participants Est. completion 2029-09-20 1 site Stand-aloneOther conditions: Solid Tumor, AdultView official trial listing → -
Not yet recruiting NCT NCT07352566
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Not yet reported University of California, San Francisco 10 participants Est. completion 2030-06-01 1 site Stand-aloneOther conditions: Psoriasis, Atopic DermatitisView official trial listing → -
Not yet recruiting NCT NCT07409740
Optical Coherence Tomography Angiography Evaluation Of Patients Taking Hydroxychloroquine
Sohag University 90 participants Est. completion 2026-09-01Other conditions: Hydroxychloroquine RetinopathyView official trial listing → -
Not yet recruiting NCT NCT07443436
Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants
Not yet reported Assistance Publique - Hôpitaux de Paris 30 participants Est. completion 2027-11-01 3 sites Stand-aloneOther conditions: Interstitial Lung DiseaseView official trial listing → -
Not yet recruiting NCT NCT07467252
AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT
Not yet reported Ministry of Health, Saudi Arabia 200 participants Est. completion 2028-06 1 site Stand-aloneOther conditions: Pulmonary TuberculosisView official trial listing → -
Not yet recruiting NCT NCT07557927
A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
Not yet reported Kunming Pharmaceuticals, Inc. 100 participants Est. completion 2028-09-30 10 sitesOther conditions: Discoid Lupus ErythematosusView official trial listing → -
Not yet recruiting NCT NCT07675291
Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children
Not yet reported Nanfang Hospital, Southern Medical University 112 participants Est. completion 2028-12-31 Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Not yet recruiting NCT NCT07814339
Hydrochloroquinine & Decitabine With Venetoclax in AML
Not yet reported Rutgers, The State University of New Jersey 18 participants Est. completion 2028-06 Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Not yet recruiting NCT NCT07830108
ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.
Not yet reported Starship Child Health, Te Toka Tumai Auckland 600 participants Est. completion 2036-12 3 sitesOther conditions: Rheumatic Fever, Rheumatic Heart Disease in Children, Acute Rheumatic Fever, Rheumatic Heart DiseaseView official trial listing → -
Not yet recruiting NCT NCT07852234
Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Moderate to Severe Primary Sjögren's Syndrome
Not yet reported Beijing Tongren Hospital 12 participants Est. completion 2027-10-01 1 site Stand-aloneOther conditions: Primary Sjögren's Syndrome (pSS)View official trial listing → -
Enrolling by invitation NCT NCT07888595
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Not yet reported Frontiers in Bioscience Research Institute and Aging 48 participants Est. completion 2028-10-14 1 siteOther conditions: AgingView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Hydroxychloroquine Sulfate, Hydroxychloroquine, Hydroxychloroquine Oral Tablet, plaquenil
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.